Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Vlassara

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Plos One|February 1, 2013
Pentosan polysulfate: a novel therapy for the mucopolysaccharidosesEdward H Schuchman, Yi Ge, Alon Lai, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2015
Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Jaime Uribarri, Weijing Cai, Mark Woodward, et al.
Mechanisms of Ageing and Development|November 15, 2011
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individualsMichal Schnaider Beeri, Erin Moshier, James Schmeidler, et al.
Human Molecular Genetics|October 24, 2002
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in miceKimihiko Oishi, Susanna Hofmann, George A Diaz, et al.
Diabetes Care|August 29, 2006
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetesAlin Stirban, Monica Negrean, Bernd Stratmann, et al.
The American Journal of Clinical Nutrition|May 11, 2007
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitusMonica Negrean, Alin Stirban, Bernd Stratmann, et al.
Clinical Chemistry and Laboratory Medicine|April 25, 2013
Increased circulating advanced glycation endproducts (AGEs) in acute trauma patientsCarl I Schulman, Jaime Uribarri, Weijing Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humansWeijing Cai, Jaime Uribarri, Li Zhu, et al.
Plos One|April 13, 2012
Effect of dietary advanced glycation end products on mouse liverRaza Patel, Susan S Baker, Wensheng Liu, et al.
The American Journal of Clinical Nutrition|December 21, 2014
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health StudyLi Jiao, Rachael Stolzenberg-Solomon, Thea Palmer Zimmerman, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Plos One|February 1, 2013
Pentosan polysulfate: a novel therapy for the mucopolysaccharidosesEdward H Schuchman, Yi Ge, Alon Lai, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2015
Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Jaime Uribarri, Weijing Cai, Mark Woodward, et al.
Mechanisms of Ageing and Development|November 15, 2011
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individualsMichal Schnaider Beeri, Erin Moshier, James Schmeidler, et al.
Human Molecular Genetics|October 24, 2002
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in miceKimihiko Oishi, Susanna Hofmann, George A Diaz, et al.
Diabetes Care|August 29, 2006
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetesAlin Stirban, Monica Negrean, Bernd Stratmann, et al.
The American Journal of Clinical Nutrition|May 11, 2007
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitusMonica Negrean, Alin Stirban, Bernd Stratmann, et al.
Clinical Chemistry and Laboratory Medicine|April 25, 2013
Increased circulating advanced glycation endproducts (AGEs) in acute trauma patientsCarl I Schulman, Jaime Uribarri, Weijing Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humansWeijing Cai, Jaime Uribarri, Li Zhu, et al.
Plos One|April 13, 2012
Effect of dietary advanced glycation end products on mouse liverRaza Patel, Susan S Baker, Wensheng Liu, et al.
The American Journal of Clinical Nutrition|December 21, 2014
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health StudyLi Jiao, Rachael Stolzenberg-Solomon, Thea Palmer Zimmerman, et al.
Pageof 9